**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| Not available |Hydrated 4-(4,6-Dimethoxy[1.3.5]triazi| >99 | unlisted |
|----------------|--------------------------------------|----------|-----------|
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: C
Risk Phrases: 20/21/22 34 40
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed. Causes
burns. Limited evidence of a carcinogenic effect.Light
sensitive.Hygroscopic (absorbs moisture from the air).
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Possible risk of irreversible effects.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes.
Ingestion:
Get medical aid immediately. Do NOT induce vomiting. If conscious
and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Avoid generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Minimize dust generation and accumulation. Do not
breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or
on clothing. Use only with adequate ventilation.
Storage:
Store in a tightly closed container. Deep freeze (below -20C).
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 0-00-0:
CAS# 3945-69-5:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 118 - 120 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H17ClN4O3
Molecular Weight: 276.72
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Not available.
Conditions to Avoid:
Light, excess heat, exposure to moist air or water.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 0-00-0 unlisted.
CAS# 3945-69-5 unlisted.
LD50/LC50:
Not available.
Not available.
Carcinogenicity:
Hydrated 4-(4,6-Dimethoxy[1.3.5]triazin-2-yl)-4- methylmorpholinium
chloride -
Not listed by ACGIH, IARC, or NTP.
4-(4,6-Dimethoxy[1.3.5]triazin-2-yl)-4-methylmorpholinium chloride
anhydrous -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
No information available.
IMO
No information available.
RID/ADR
No information available.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 34 Causes burns.
R 40 Limited evidence of a carcinogenic effect.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 0-00-0: No information available.
CAS# 3945-69-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 0-00-0 is not listed on Canada's Ingredient Disclosure List.
CAS# 3945-69-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 0-00-0 is not listed on the TSCA inventory.
It is for research and development use only.
CAS# 3945-69-5 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 8/04/2000 Revision #1 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Methyl 4-amino-3-bromobenzoate
| 106896-49-5 |
|
2,4-Dichloro-5-hydroxyaniline
| 39489-79-7 |
|
6-Chloro-4-trifluoromethoxyaniline
| 0-01-1 |
|
2,4-Dibromo-6-methylaniline
| 30273-41-7 |
|
1,4-Bis(trichloromethyl)benzene, 99%
| 68-36-0 |
|
Nicotinamide, p.a.
| 98-92-0 |
|
6-Chloro-9-(3-N-(2-chloroethyl-amino)-propylamino-2-methoxyacridine
| 17064-47-0 |
|
2-Amino-5-bromobenzotrifluoride
| 445-02-3 |
|
N,N'-p-Phenylenedimaleimide
| 3278-31-7 |
|
N,N'-m-Phenylenedimaleimide
| 3006-93-7 |
|
Allyltrimethylsilane, 97%
| 762-72-1 |
|
Celite 545
| 68855-54-9 |
|
3-Bromo-1-propanol, 97%
| 627-18-9 |
|
1,2-Epoxy-2-methylbutane
| 30095-63-7 |
|
2,3-Epoxy-2-methylbutane
| 5076-19-7 |
|
Dicyclopentadiene diepoxide
| 81-21-0 |
|
1-(3-Methylphenyl)-piperazine, 99%
| 41186-03-2 |
|
Lithium bis(trimethylsilyl)amide, 23% in methyl tert-butyl ether
| 100-41-4 |
|
Lithium bis(trimethylsilyl)amide, 20% in THF
| 100-41-4 |
|
2(2-Bromoethyl)-1,3-dioxolane, 96%
| 18742-02-4 |
|
N-(Phenylseleno)phthalimide, tech.
| 71098-88-9 |
|
Brij?? 98
| 9004-98-2 |
|
4-Fluoro-N-methylaniline
| 459-59-6 |
|
3,4,5-Trimethoxyacetophenone, 99+%
| 1136-86-3 |
|
Potassium tetracyanonickelate(II) hydrate
| 14220-17-8 |
|
Zinc peroxide, 55%
| 1314-22-3 |
|
3,4-Dimethyl-3,4-diphenylhexane
| 10192-93-5 |
|
1,4-Naphthalenediol (pract), 95% (uv-vis)
| 571-60-8 |
|
2,3-Dimethyl-2,3-diphenylbutane
| 1889-67-4 |
|
Dicumyl peroxide
| 80-43-3 |
|
Cumyl hydroperoxide
| 80-15-9 |
|
tert-Butyl cumyl peroxide
| 98-82-8 |
|
3,6,9-Triethyl-3,6,9-trimethyl-1,4,7-triperoxynonane, 41% solution in
| 24748-23-0 |
|
Di(tert-butylperoxyisopropyl)benzene
| 2212-81-9 |
|
tert-Butyl peroxy-3,5,5-trimethylhexanoate
| 13122-18-4 |
|
tert-Butylperoxy 2-ethylhexyl carbonate
| 34443-12-4 |
|
Di-tert-butyl peroxide
| 110-05-4 |
|
1,1-Di(tert-butylperoxy)cyclohexane, 50% solution in aromatic free
| 3006-86-8 |
|
Lauroyl peroxide
| 105-74-8 |
|
tert-Butyl peroxyacetate, 50% solution in aromatic free mineral
| 107-71-1 |
|
2,5-Dimethyl-2,5-di(tert-butylperoxy)hexane
| 78-63-7 |
|
2,2-Di(tert-butylperoxy)butane, 50% solution in aromatic free mineral
| 78-93-3 |
|
Benzoylformic acid, 97%
| 611-73-4 |
|
Ethyl 7-bromoheptanoate
| 29823-18-5 |
|
16-Hydroxyhexadecanoic Acid, 98%
| 506-13-8 |
|
4-(4,6-Dimethoxy[1.3.5]triazin-2-yl)-4-methylmorpholinium chloride
| 0-00-0 |
|
3-Methoxysalicylic acid, 97%
| 877-22-5 |
|
d-alpha-Tocopherylquinone, 90-95%
| 7559-04-8 |
|
Dibutyl Maleate
| 105-76-0 |
|
Glutathione-Agarose, 4% cross-linked
| 0-01-1 |
|
|